Template:Monoamine reuptake inhibitors: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
m 1 revision imported |
||
| (One intermediate revision by one other user not shown) | |||
| Line 17: | Line 17: | ||
* [[GBR-13069]] | * [[GBR-13069]] | ||
* [[GBR-13098]] | * [[GBR-13098]] | ||
* [[JJC8-088]] | |||
* [[Nefazodone]] | * [[Nefazodone]] | ||
* [[Vanoxerine]] | * [[Vanoxerine]] | ||
| Line 32: | Line 33: | ||
* [[Phencyclidine]] | * [[Phencyclidine]] | ||
* [[Pipradrol]] | * [[Pipradrol]] | ||
* [[Serdexmethylphenidate]] | |||
* [[Tenocyclidine]] | * [[Tenocyclidine]] | ||
| Line 79: | Line 81: | ||
* [[Butyltolylquinuclidine|BTQ]] | * [[Butyltolylquinuclidine|BTQ]] | ||
* [[BTS 74,398]] | * [[BTS 74,398]] | ||
* [[Bupropion]] | * [[Bupropion]] | ||
* ''[[Chaenomeles speciosa]]'' | * ''[[Chaenomeles speciosa]]'' | ||
* [[Ciclazindol]] | * [[Ciclazindol]] | ||
* [[Dasotraline]] | * [[Dasotraline]] | ||
* [[Desmethylsertraline]] | * [[Desmethylsertraline]] | ||
* [[Desmethylsibutramine]] | * [[Desmethylsibutramine|Desmethylsibutramine (BTS-54354)]] | ||
* [[Diclofensine]] | * [[Diclofensine]] | ||
* [[Didesmethylsibutramine]] | * [[Didesmethylsibutramine|Didesmethylsibutramine (BTS-54505)]] | ||
* [[Dimethocaine]] | * [[Dimethocaine]] | ||
* [[Diphenylpyraline]] | * [[Diphenylpyraline]] | ||
| Line 100: | Line 102: | ||
* [[Fluorenol]] | * [[Fluorenol]] | ||
* [[GYKI-52895]] | * [[GYKI-52895]] | ||
* [[Hydroxybupropion]] | |||
* [[Indatraline]] | * [[Indatraline]] | ||
* [[Ketamine]] | * [[Ketamine]] | ||
* [[Lafadofensine]] | |||
* [[Lefetamine]] | * [[Lefetamine]] | ||
* [[Levophacetoperane]] | * [[Levophacetoperane]] | ||
| Line 127: | Line 131: | ||
* [[Tametraline]] | * [[Tametraline]] | ||
* [[Tedatioxetine]] | * [[Tedatioxetine]] | ||
* [[Threohydrobupropion]] | |||
* [[Tripelennamine]] | * [[Tripelennamine]] | ||
* [[Venlafaxine]]<!--Extremely weak--> | * [[Venlafaxine]]<!--Extremely weak--> | ||
| Line 166: | Line 171: | ||
* [[O-2172]] | * [[O-2172]] | ||
* [[Radafaxine]] | * [[Radafaxine]] | ||
* [[Serdexmethylphenidate]] | |||
* [[Solriamfetol]] | * [[Solriamfetol]] | ||
| list3 = | | list3 = | ||
* ''Serotonin–norepinephrine reuptake inhibitors:'' [[Atomoxetine|Atomoxetine (tomoxetine)]] | * ''Serotonin–norepinephrine reuptake inhibitors:'' [[Atomoxetine|Atomoxetine (tomoxetine)]] | ||
* [[CP-39,332]] | * [[CP-39,332]] | ||
* [[Desvenlafaxine]] | * [[Desvenlafaxine]] | ||
| Line 176: | Line 181: | ||
* [[Eclanamine]] | * [[Eclanamine]] | ||
* [[Levomilnacipran]] | * [[Levomilnacipran]] | ||
* [[ | * [[McN5652]] | ||
* [[Milnacipran]] | * [[Milnacipran]] | ||
* [[N-Methyl-PPPA]] | * [[N-Methyl-PPPA]] | ||
| Line 183: | Line 188: | ||
* [[Tofenacin]] | * [[Tofenacin]] | ||
* [[Venlafaxine]] | * [[Venlafaxine]] | ||
| list4 = | | list4 = | ||
| Line 195: | Line 199: | ||
* [[Dasotraline]] | * [[Dasotraline]] | ||
* [[Desmethylsertraline]] | * [[Desmethylsertraline]] | ||
* [[Desmethylsibutramine]] | * [[Desmethylsibutramine|Desmethylsibutramine (BTS-54354)]] | ||
* [[Diclofensine]] | * [[Diclofensine]] | ||
* [[Didesmethylsibutramine]] | * [[Didesmethylsibutramine|Didesmethylsibutramine (BTS-54505)]] | ||
* [[DOV-102677]] | * [[DOV-102677]] | ||
* [[DOV-216303]] | * [[DOV-216303]] | ||
| Line 203: | Line 207: | ||
* [[Fezolamine]] | * [[Fezolamine]] | ||
* [[HDMP-28]] | * [[HDMP-28]] | ||
* [[HP-505]] | |||
* [[Indatraline]] | * [[Indatraline]] | ||
* [[JNJ-7925476]] | * [[JNJ-7925476]] | ||
* [[JZ-IV-10]] | * [[JZ-IV-10]] | ||
* [[Lafadofensine]] | |||
* [[Liafensine]] | * [[Liafensine]] | ||
* [[Mazindol]] | * [[Mazindol]] | ||
| Line 220: | Line 226: | ||
* [[Tedatioxetine]] | * [[Tedatioxetine]] | ||
* [[Tesofensine]] | * [[Tesofensine]] | ||
* [[Threohydrobupropion]] | |||
* [[Tropane]]s (e.g., [[cocaine]]) | * [[Tropane]]s (e.g., [[cocaine]]) | ||
| Line 261: | Line 268: | ||
| list1 = | | list1 = | ||
* ''Selective serotonin reuptake inhibitors:'' [[Alaproclate]] | * ''Selective serotonin reuptake inhibitors:'' [[6-Nitroquipazine]] | ||
* [[Alaproclate]] | |||
* [[Centpropazine]] | * [[Centpropazine]] | ||
* [[Cericlamine]] | * [[Cericlamine]] | ||
| Line 289: | Line 297: | ||
* [[Lubazodone]] | * [[Lubazodone]] | ||
* [[LY-393558]] | * [[LY-393558]] | ||
* [[Quipazine]] | |||
* [[SB-649915]] | * [[SB-649915]] | ||
* [[TGBA01AD]] | * [[TGBA01AD]] | ||
| Line 298: | Line 307: | ||
* ''Serotonin–norepinephrine reuptake inhibitors:'' [[Atomoxetine|Atomoxetine (tomoxetine)]] | * ''Serotonin–norepinephrine reuptake inhibitors:'' [[Atomoxetine|Atomoxetine (tomoxetine)]] | ||
* [[Bicifadine]] | * [[Bicifadine]] | ||
* [[CP-39332]] | * [[CP-39332]] | ||
* [[Desvenlafaxine]] | * [[Desvenlafaxine]] | ||
| Line 304: | Line 312: | ||
* [[Eclanamine]] | * [[Eclanamine]] | ||
* [[Levomilnacipran]] | * [[Levomilnacipran]] | ||
* [[ | * [[McN5652]] | ||
* [[Milnacipran]] | * [[Milnacipran]] | ||
* [[N-Methyl-PPPA]] | * [[N-Methyl-PPPA]] | ||
| Line 310: | Line 318: | ||
* [[Tofenacin]] | * [[Tofenacin]] | ||
* [[Venlafaxine]] | * [[Venlafaxine]] | ||
| list3 = | | list3 = | ||
| Line 322: | Line 329: | ||
* [[Dasotraline]] | * [[Dasotraline]] | ||
* [[Desmethylsertraline]] | * [[Desmethylsertraline]] | ||
* [[Desmethylsibutramine]] | * [[Desmethylsibutramine|Desmethylsibutramine (BTS-54354)]] | ||
* [[Diclofensine]] | * [[Diclofensine]] | ||
* [[Didesmethylsibutramine]] | * [[Didesmethylsibutramine|Didesmethylsibutramine (BTS-54505)]] | ||
* [[DOV-102677]] | * [[DOV-102677]] | ||
* [[DOV-216303]] | * [[DOV-216303]] | ||
| Line 330: | Line 337: | ||
* [[Fezolamine]] | * [[Fezolamine]] | ||
* [[HDMP-28]] | * [[HDMP-28]] | ||
* [[HP-505]] | |||
* [[Indatraline]] | * [[Indatraline]] | ||
* [[JNJ-7925476]] | * [[JNJ-7925476]] | ||
* [[JZ-IV-10]] | * [[JZ-IV-10]] | ||
* [[Lafadofensine]] | |||
* [[Liafensine]] | * [[Liafensine]] | ||
* [[Mazindol]] | * [[Mazindol]] | ||
| Line 347: | Line 356: | ||
* [[Tedatioxetine]] | * [[Tedatioxetine]] | ||
* [[Tesofensine]] | * [[Tesofensine]] | ||
* [[Threohydrobupropion]] | |||
* [[Tropane]]s (e.g., [[cocaine]]) | * [[Tropane]]s (e.g., [[cocaine]]) | ||
| Line 374: | Line 384: | ||
* [[Dextrorphan]] | * [[Dextrorphan]] | ||
* [[Efavirenz]] | * [[Efavirenz]] | ||
* [[Hypidone]] | |||
* [[Medifoxamine]] | * [[Medifoxamine]] | ||
* [[Mesembrine]] | * [[Mesembrine]] | ||
| Line 409: | Line 420: | ||
| group5 = Others | | group5 = Others | ||
| list5 = | | list5 = | ||
* ''Unsorted:'' [[Cendifensine]]<!-- (3,4-Dichlorophenyl)[(3S)-3-propyl-3-pyrrolidinyl]methanone; CAS # 1034048-49-1 --> | |||
* ''DAT enhancers:'' [[Luteolin]] | * ''DAT enhancers:'' [[Luteolin]] | ||
| Line 420: | Line 433: | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
</noinclude> | </noinclude> | ||
Latest revision as of 19:44, 8 March 2025
| Monoamine reuptake inhibitors | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
